Larvol Delta - Bridging-the-Treatment-Access-Gap-Janus-Kinase-Inhibitors-as-Firstline-Advanced-Therapy-for-Inflammatory-Bowel-Disease-in-Resourcevariable-Settings

tofacitinib - Generic mfg.

Stelara (ustekinumab) - J&J

Rinvoq (upadacitinib) - AbbVie

Entyvio (vedolizumab) - Takeda

http://www.ncbi.nlm.nih.gov/pubmed/42798690

Benjamin Hewitt; Rowan Bandaranaike; Samuel Tarwater

Sep 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next